Published in Cancer on January 15, 1992
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys (1995) 3.86
Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys (1988) 2.95
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation. Int J Radiat Oncol Biol Phys (1996) 2.76
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol (1997) 2.75
Cell culture of human colon adenomas and carcinomas. Cancer Res (1987) 2.68
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem (1997) 2.42
External beam radiation therapy for prostate cancer. CA Cancer J Clin (2001) 2.26
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA (1999) 2.16
Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res (1998) 2.04
Comparison of 1 vs 2 or more intracavitary brachytherapy applications in the management of carcinoma of the cervix, with irradiation alone. Int J Radiat Oncol Biol Phys (1991) 1.93
Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol (2000) 1.92
A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys (1999) 1.89
Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys (1999) 1.89
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. Int J Radiat Oncol Biol Phys (1991) 1.88
Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol (1998) 1.80
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys (2001) 1.76
Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys (2000) 1.75
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1998) 1.72
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. J Clin Oncol (2004) 1.72
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer (1993) 1.69
Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci U S A (1993) 1.66
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys (1993) 1.66
Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys (1997) 1.65
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys (1991) 1.62
Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci U S A (1998) 1.59
Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys (1995) 1.55
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys (2000) 1.54
Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci U S A (1996) 1.54
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys (1991) 1.50
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg (2001) 1.50
Establishment and characterization of human colorectal cancer cell lines. Cancer Res (1984) 1.50
Axillary web syndrome after axillary dissection. Am J Surg (2001) 1.49
Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a phase II study from Radiation Therapy Oncology Group 85-04. Ann Surg Oncol (1995) 1.49
Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys (1990) 1.48
Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol (1997) 1.46
Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg (1999) 1.45
Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys (1995) 1.44
Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int J Radiat Oncol Biol Phys (1996) 1.43
Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys (1995) 1.42
A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer (1998) 1.41
Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor. J Immunol (1977) 1.39
A comparison of prostate cancer treatments: are therapeutic implications justified? Cancer J Sci Am (1997) 1.38
A comparison of the structure of radiation oncology in the United States and Japan. Int J Radiat Oncol Biol Phys (1996) 1.37
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.36
Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys (1995) 1.35
The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys (1991) 1.30
Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer (1983) 1.30
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A (1998) 1.28
A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg (1995) 1.26
Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys (1996) 1.25
Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J (2000) 1.25
NCCN Practice Guidelines for Prostate Cancer. Oncology (Williston Park) (2000) 1.19
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer (2000) 1.18
Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys (1997) 1.18
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol (2001) 1.18
A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am (1999) 1.17
Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol (1994) 1.17
Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.15
A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys (1987) 1.14
Adenocarcinoma in regional enteritis of the small intestine. Arch Surg (1977) 1.14
Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys (1991) 1.14
The need for complex technology in radiation oncology. Correlations of facility characteristics and structure with outcome. Cancer (1985) 1.14
Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene (1996) 1.13
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol (1992) 1.13
Hypoxic regions exist in human prostate carcinoma. Urology (1999) 1.13
Prostate cancer risk assessment program. A model for the early detection of prostate cancer. Oncology (Williston Park) (1999) 1.11
Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. J Cutan Pathol (2001) 1.11
Lymphoma of the breast. Ann Surg (1981) 1.11
Hypoxia in human prostate carcinoma: an Eppendorf PO2 study. Am J Clin Oncol (2001) 1.10
Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys (1995) 1.09
Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys (1997) 1.09
Endoscopic transrectal resection of rectal carcinomas using the urologic resectoscope. Dis Colon Rectum (1984) 1.08
Do operations facilitate tumor growth? An experimental model in rats. Surgery (1986) 1.08
Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys (1995) 1.08
Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol (1997) 1.08
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol (1998) 1.07
Gastrointestinal stromal tumors. Curr Treat Options Oncol (2001) 1.07
Megavoltage radiation therapy and lymphangiography in ovarian cancer. Radiology (1969) 1.07